|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tryggvadóttir L, Gislum M, Hakulinen T,
Klint A, Engholm G, Storm HH and Bray F: Trends in the survival of
patients diagnosed with malignant melanoma of the skin in the
Nordic countries 1964–2003 followed up to the end of 2006. Acta
Oncol. 49:665–672. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hollestein LM, de Vries E and Nijsten T:
Trends of cutaneous squamous cell carcinoma in the Netherlands:
Increased incidence rates, but stable relative survival and
mortality 1989–2008. Eur J Cancer. 48:2046–2053. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
de Vries E, Bray FI, Coebergh JW and
Parkin DM: Changing epidemiology of malignant cutaneous melanoma in
Europe 1953–1997: Rising trends in incidence and mortality but
recent stabilizations in western Europe and decreases in
Scandinavia. Int J Cancer. 107:119–126. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Garbe C and Leiter U: Melanoma
epidemiology and trends. Clin Dermatol. 27:3–9. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Qin J, Berwick M, Ashbolt R and Dwyer T:
Quantifying the change of melanoma incidence by Breslow thickness.
Biometrics. 58:665–670. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lipsker D, Engel F, Cribier B, Velten M
and Hedelin G: Trends in melanoma epidemiology suggest three
different types of melanoma. Br J Dermatol. 157:338–343. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Erdmann F, Lortet-Tieulent J, Schüz J,
Zeeb H, Greinert R, Breitbart EW and Bray F: International trends
in the incidence of malignant melanoma 1953–2008 - are recent
generations at higher or lower risk? Int J Cancer. 132:385–400.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Coory M, Baade P, Aitken J, Smithers M,
McLeod GR and Ring I: Trends for in situ and invasive
melanoma in Queensland, Australia, 1982–2002. Cancer Causes
Control. 17:21–27. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jemal A, Saraiya M, Patel P, Cherala SS,
Barnholtz-Sloan J, Kim J, Wiggins CL and Wingo PA: Recent trends in
cutaneous melanoma incidence and death rates in the United States,
1992–2006. J Am Acad Dermatol. 65:S17–S25. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
MacKie RM, Bray C, Vestey J, Doherty V,
Evans A, Thomson D and Nicolson M: Scottish Melanoma Group:
Melanoma incidence and mortality in Scotland 1979–2003. Br J
Cancer. 96:1772–1777. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
de Vries E, Schouten LJ, Visser O,
Eggermont AM and Coebergh JW: Working Group of Regional Cancer
Registries: Rising trends in the incidence of and mortality from
cutaneous melanoma in the Netherlands: A Northwest to Southeast
gradient? Eur J Cancer. 39:1439–1446. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Anderson WF, Pfeiffer RM, Tucker MA and
Rosenberg PS: Divergent cancer pathways for early-onset and
late-onset cutaneous malignant melanoma. Cancer. 115:4176–4185.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gandini S, Sera F, Cattaruzza MS, Pasquini
P, Picconi O, Boyle P and Melchi CF: Meta-analysis of risk factors
for cutaneous melanoma: II. Sun exposure. Eur J Cancer. 41:45–60.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
El Ghissassi F, Baan R, Straif K, Grosse
Y, Secretan B, Bouvard V, Benbrahim-Tallaa L, Guha N, Freeman C,
Galichet L and Cogliano V: WHO International Agency for Research on
Cancer Monograph Working Group: A review of human carcinogens -
part D: Radiation. Lancet Oncol. 10:751–752. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zittermann A, Iodice S, Pilz S, Grant WB,
Bagnardi V and Gandini S: Vitamin D deficiency and mortality risk
in the general population: A meta-analysis of prospective cohort
studies. Am J Clin Nutr. 95:91–100. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gandini S, Boniol M, Haukka J, Byrnes G,
Cox B, Sneyd MJ, Mullie P and Autier P: Meta-analysis of
observational studies of serum 25-hydroxyvitamin D levels and
colorectal, breast and prostate cancer and colorectal adenoma. Int
J Cancer. 128:1414–1424. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gandini S, Raimondi S, Gnagnarella P, Doré
JF, Maisonneuve P and Testori A: Vitamin D and skin cancer: A
meta-analysis. Eur J Cancer. 45:634–641. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gnagnarella P, Pasquali E, Serrano D,
Raimondi S, Disalvatore D and Gandini S: Vitamin D receptor
polymorphism FokI and cancer risk: A comprehensive meta-analysis.
Carcinogenesis. 35:1913–1919. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Boniol M, Autier P, Boyle P and Gandini S:
Cutaneous melanoma attributable to sunbed use: Systematic review
and meta-analysis. BMJ. 345:e47572012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Berwick M, Armstrong BK, Ben-Porat L, Fine
J, Kricker A, Eberle C and Barnhill R: Sun exposure and mortality
from melanoma. J Natl Cancer Inst. 97:195–199. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang L, Lof M, Veierød MB, Sandin S, Adami
HO and Weiderpass E: Ultraviolet exposure and mortality among women
in Sweden. Cancer Epidemiol Biomarkers Prev. 20:683–690. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
US Food and Drug Administration: US Food
and Drug Administration-21 CFR Part 11: Electronic Records;
Electronic Signatures. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=11Accessed.
May 28–2008
|
|
24
|
Fitzpatrick TB: The validity and
practicality of sun-reactive skin types I through VI. Arch
Dermatol. 124:869–871. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gandini S, De Vries E, Tosti G, Botteri E,
Spadola G, Maisonneuve P, Martinoli C, Joosse A, Ferrucci PF,
Baldini F, et al: Sunny holidays before and after melanoma
diagnosis are respectively associated with lower Breslow thickness
and lower relapse rates in Italy. PLoS One. 8:e788202013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mandalá M, Imberti GL, Piazzalunga D,
Belfiglio M, Lucisano G, Labianca R, Marchesi L, Merelli B, Robone
S, Poletti P, et al: Association of socioeconomic status with
Breslow thickness and disease-free and overall survival in stage
I–II primary cutaneous melanoma. Mayo Clin Proc. 86:113–119. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rosso S, Sera F, Segnan N and Zanetti R:
Sun exposure prior to diagnosis is associated with improved
survival in melanoma patients: Results from a long-term follow-up
study of Italian patients. Eur J Cancer. 44:1275–1281. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Berwick M, Reiner AS, Paine S, Armstrong
BK, Kricker A, Goumas C, Cust AE, Thomas NE, Groben PA, From L, et
al: Sun exposure and melanoma survival: A GEM study. Cancer
Epidemiol Biomarkers Prev. 23:2145–2152. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Egan KM, Sosman JA and Blot WJ: Sunlight
and reduced risk of cancer: Is the real story vitamin D? J Natl
Cancer Inst. 97:161–163. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Autier P and Gandini S: Vitamin D
supplementation and total mortality: A meta-analysis of randomized
controlled trials. Arch Intern Med. 167:1730–1737. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Randerson-Moor JA, Taylor JC, Elliott F,
Chang YM, Beswick S, Kukalizch K, Affleck P, Leake S, Haynes S,
Karpavicius B, et al: Vitamin D receptor gene polymorphisms, serum
25-hydroxyvitamin D levels, and melanoma: UK case-control
comparisons and a meta-analysis of published VDR data. Eur J
Cancer. 45:3271–3281. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Newton-Bishop J, Beswick S, Jackon S, Moor
Renderson J, Elliott F, Barrett J, Affleck P, Marsden J and Bishop
T: Vitamin D and survival from melanoma. Melanoma Res. 16:S26–S27.
2006. View Article : Google Scholar
|
|
33
|
Raimondi S, Johansson H, Maisonneuve P and
Gandini S: Review and meta-analysis on vitamin D receptor
polymorphisms and cancer risk. Carcinogenesis. 30:1170–1180. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Newton-Bishop JA, Beswick S,
Randerson-Moor J, Chang YM, Affleck P, Elliott F, Chan M, Leake S,
Karpavicius B, Haynes S, et al: Serum 25-hydroxyvitamin D3 levels
are associated with breslow thickness at presentation and survival
from melanoma. J Clin Oncol. 27:5439–5444. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gilchrest BA, Eller MS, Geller AC and Yaar
M: The pathogenesis of melanoma induced by ultraviolet radiation. N
Engl J Med. 340:1341–1348. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Berwick M, Armstrong BK, Ben-Porat L, Fine
J, Kricker A, Eberle C and Barnhill R: Sun exposure and mortality
from melanoma. J Natl Cancer Inst. 97:195–199. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ambrosini-Spaltro A, Dal Cappello T,
Deluca J, Carriere C, Mazzoleni G and Eisendle K: Melanoma
incidence and Breslow tumour thickness development in the central
Alpine region of South Tyrol from 1998 to 2012: A population-based
study. J Eur Acad Dermatol Venereol. 29:243–248. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Guerrieri-Gonzaga A and Gandini S: Vitamin
D and overall mortality. Pigment Cell Melanoma Res. 26:16–28. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gandini S, Francesco F, Johanson H,
Bonanni B and Testori A: Why vitamin D for cancer patients?
Ecancermedicalscience. 3:1602009.PubMed/NCBI
|
